Anti-angiotensin II type 1 receptor autoantibodies (AT1R-AAs) in patients with systemic sclerosis: lack of association with disease manifestations.

about

Anti-angiotensin II type 1 receptor autoantibodies (AT1R-AAs) in patients with systemic sclerosis: lack of association with disease manifestations.

Item

http://www.wikidata.org/entity/Q39076219

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Anti-angiotensin II type 1 rec ...... n with disease manifestations.

@en

Anti-angiotensin II type 1 receptor autoantibodies

@nl

type

Item

label

Anti-angiotensin II type 1 rec ...... n with disease manifestations.

@en

Anti-angiotensin II type 1 receptor autoantibodies

@nl

prefLabel

Anti-angiotensin II type 1 rec ...... n with disease manifestations.

@en

Anti-angiotensin II type 1 receptor autoantibodies

@nl

P1476

Anti-angiotensin II type 1 rec ...... on with disease manifestations

@en

P2093

Nurşen Düzgün

http://www.w3.org/2001/XMLSchema#string

P2860

Receptor-activating autoantibodies and disease: preeclampsia and beyond.

Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis.

Association of anti-human leukocyte antigen and anti-angiotensin II type 1 receptor antibodies with liver allograft fibrosis after immunosuppression withdrawal.

Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.

C4d-negative antibody-mediated rejection with high anti-angiotensin II type I receptor antibodies in absence of donor-specific antibodies.

Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies.

Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis.

Involvement of functional autoantibodies against vascular receptors in systemic sclerosis.

The clinicopathological relevance of pretransplant anti-angiotensin II type 1 receptor antibodies in renal transplantation.

Clinical implications of angiotensin II type 1 receptor antibodies in antibody-mediated rejection without detectable donor-specific HLA antibodies after renal transplantation.

P2888

s00296-016-3639-4

P304

593-598

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00296-016-3639-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ufuk İlgen

Müçteba Enes Yayla

P577

2016-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28004166

http://www.w3.org/2001/XMLSchema#string

P921

autoantibody